CARCINOMA, RENAL CELL
Clinical trials for CARCINOMA, RENAL CELL explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, RENAL CELL trials appear
Sign up with your email to follow new studies for CARCINOMA, RENAL CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo enters human testing for Tough-to-Treat cancers
Disease control OngoingThis is an early-stage study to find a safe dose of a new drug called KFA115, both by itself and combined with an existing immunotherapy (pembrolizumab). It involves about 126 adults with various advanced cancers that have stopped responding to standard treatments. The main goal …
Matched conditions: CARCINOMA, RENAL CELL
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 03, 2026 22:55 UTC
-
New drug cocktail tested for fighting advanced kidney cancer
Disease control OngoingThis study is testing experimental combinations of immune and targeted drugs for people with advanced kidney cancer that has spread. The research aims to find safe and effective treatment options for 400 participants who haven't received prior treatment for their advanced cancer.…
Matched conditions: CARCINOMA, RENAL CELL
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New drug combo trial offers hope for Tough-to-Treat kidney cancer
Disease control OngoingThis study is testing whether a new combination of two drugs (belzutifan plus lenvatinib) works better than an existing drug (cabozantinib) for people with advanced kidney cancer that has continued to grow despite prior immunotherapy. The main goals are to see which treatment hel…
Matched conditions: CARCINOMA, RENAL CELL
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New hope for Tough-to-Treat kidney cancer: targeted drug trial enters final phase
Disease control OngoingThis study is testing a new targeted drug called savolitinib for people with an advanced form of kidney cancer called MET-driven papillary renal cell carcinoma (PRCC). It compares savolitinib directly against sunitinib, a standard treatment, to see which is better at controlling …
Matched conditions: CARCINOMA, RENAL CELL
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Breakthrough combo trial aims to extend lives of kidney cancer patients
Disease control OngoingThis study is testing whether adding one or two new drugs to the standard treatment works better for advanced kidney cancer. It involves about 249 Chinese patients who haven't had previous treatment for their advanced cancer. Researchers will compare how long patients live withou…
Matched conditions: CARCINOMA, RENAL CELL
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC
-
Scientists track immune cells to learn why cancer treatments work
Knowledge-focused OngoingThis study aims to learn how the immune system changes when patients with advanced kidney or bladder cancer receive immunotherapy drugs. Researchers will collect blood samples from about 67 patients before and during treatment to measure different immune cells and cancer cells in…
Matched conditions: CARCINOMA, RENAL CELL
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC